Kristian Humer - 31 Dec 2021 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
CFO and CBO
Signature
/s/ Lara Meisner, Attorney-in-Fact for Kristian Humer
Issuer symbol
VRDN
Transactions as of
31 Dec 2021
Net transactions value
$0
Form type
4
Filing time
03 Jan 2022, 15:16:04 UTC
Previous filing
02 Aug 2021
Next filing
03 Feb 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRDN Stock Option (Right to Buy) Award $0 +121,371 $0.000000 121,371 31 Dec 2021 Common Stock 121,371 $19.77 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests 25% on July 26, 2022 and then in equal monthly installments over the following 3 years, subject to the Reporting Person's continued service to Issuer through each vesting date.